|
| Press Releases |
|
 |
|
| Friday, April 3, 2020 |
|
|
아방스 클리니컬, APAC 바이오테크 고객사들이 임상시험을 위해 호주를 선택하는 주요 이유 밝혀 |
| 호주의 임상시험수탁기관(CRO)인 아방스 클리니컬(Avance Clinical)은 클라이언트 온보딩 피드백을 토대로 APAC 바이오테크 기업들이 초기 임상시험을 위해 호주를 선택하는 주요 이유를 오늘 밝혔다. more info >> |
|
| Thursday, April 2, 2020 |
|
|
Avance Clinical on Top Reasons APAC Biotech Clients Choose Australia for Clinical Trials |
| Leading Australian CRO Avance Clinical today detailed the top reasons its APAC biotechs selected Australia for their early phase clinical trials, based on client onboarding feedback. more info >> |
|
| Friday, March 20, 2020 |
|
|
澳大利亞CRO, Avance Clinical公司在COVID-19疫苗和臨床試驗治療方案方面具有得天獨厚的優勢 |
| 澳大利亞CRO Avance Clinical今天表示，澳大利亞快速的監管審批環境，關鍵意見領袖的專業知識和高質量的臨床研究中心，以及頗具吸引力的40%的政府臨床試驗支出退稅，所有這一切都意味著Avance具有得天獨厚的優勢，能夠使緊迫的COVID-19試驗速見成效。 more info >> |
|
|
澳大利亚CRO, Avance Clinical公司在COVID-19疫苗和临床试验治疗方案方面具有得天独厚的优势 |
| 澳大利亚CRO Avance Clinical今天表示，澳大利亚快速的监管审批环境，关键意见领袖的专业知识和高质量的临床研究中心，以及颇具吸引力的40%的政府临床试验支出退税，所有这一切都意味着Avance具有得天独厚的优势，能够使紧迫的COVID-19试验速见成效。 more info >> |
|
|
호주 임상시험수탁기관인 아방스 클리니컬, COVID-19 백신 및 치료제 개발을 위한 임상시험에 독보적 위치 점유 |
| 호주의 임상시험수탁기관(CRO)인 아방스 클리니컬(Avance Clinical)은 호주의 빠른 규제 승인 환경과 주요 오피니언 리더들의 전문성, 고품질 임상 연구소 및 임상시험 지출에 대해 정부가 지급하는 40%의 보조금 등으로 인해 자신들이 COVID-19 관련 임상시험에서 신속히 결과를 낼 수 있는 유리한 위치에 있다고 오늘 밝혔다. more info >> |
|
|
Australian CRO, Avance Clinical is Uniquely Positioned for COVID-19 Vaccines and Therapies Clinical Trials |
| Australian CRO Avance Clinical said today that Australia's fast regulatory approval environment, key opinion leader expertise and high-quality clinical research sites, as well as the attractive 40% Government rebate on clinical trial spend, means Avance is uniquely positioned to deliver rapid results for urgent COVID-19 trials. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
海通恒信2025年報：協同效應加速釋放 新興賽道引領結構升級
Apr 3, 2026 20:28 HKT/SGT
|
|
|
海通恒信2025年报：协同效应加速释放 新兴赛道引领结构升级
Apr 3, 2026 19:43 HKT/SGT
|
|
|
HKTDC's response to World Trade Organization's latest report
Apr 3, 2026 17:11: JST
|
|
|
新希望乳業攜手香港十字牌 借道本土老字號共拓港澳市場
Apr 3, 2026 16:51 HKT/SGT
|
|
|
新希望乳业携手香港十字牌 借道本土老字号共拓港澳市场
Apr 3, 2026 16:44 HKT/SGT
|
|
|
新希望乳業與香港十字牌達成戰略合作：雙方充分發揮資源稟賦 助力港澳乳品行業高質量發展
Apr 3, 2026 16:38 HKT/SGT
|
|
|
新希望乳业与香港十字牌达成战略合作：双方充分发挥资源禀赋 助力港澳乳品行业高质量发展
Apr 3, 2026 16:26 HKT/SGT
|
|
|
HKTDC's response to World Trade Organization's latest report
Apr 3, 2026 16:11 HKT/SGT
|
|
|
マツダ、2026年度の参加型モータースポーツ活動計画を発表
Apr 3, 2026 12:00: JST
|
|
|
Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
Apr 3, 2026 12:33 JST
|
|
|
Hitachi Rail announces agreement to acquire Clever Devices, marking its growth as a global digital mobility player
Apr 3, 2026 11:09 JST
|
|
|
Datavault AI 執行長納撒尼爾·布拉德利將於 XRP Tokyo 2026 大會上介紹 DataValue(R)、DataScore(R) 及 Information Data Exchange(R) 技術
Apr 3, 2026 07:00 HKT/SGT
|
|
|
Datavault AI 首席执行官纳撒尼尔·布拉德利将在 XRP 东京 2026 大会上介绍 DataValue(R)、DataScore(R) 和 Information Data Exchange(R) 技术
Apr 3, 2026 07:00 HKT/SGT
|
|
|
Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Apr 3, 2026 07:00 HKT/SGT
|
|
|
OMRON Healthcare and UCSF launch AFib trial
Apr 2, 2026 0:00 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
